FDA approves Gilead’s Veklury for COVID-19 patients with severe renal impairment

Gilead Sciences said that the US Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Veklury (remdesivir) usage in COVID-19 ... Read More